Rockefeller Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $641K | Hold |
10,000
| – | – | ﹤0.01% | 1480 |
|
|
2025
Q1 | $634K | Sell |
10,000
-19
| -0.2% | -$1.21K | ﹤0.01% | 1408 |
|
|
2024
Q4 | $667K | Hold |
10,019
| – | – | ﹤0.01% | 1386 |
|
|
2024
Q3 | $700K | Hold |
10,019
| – | – | ﹤0.01% | 1342 |
|
|
2024
Q2 | $649K | Hold |
10,019
| – | – | ﹤0.01% | 1359 |
|
|
2024
Q1 | $648K | Sell |
10,019
-41
| -0.4% | -$2.65K | ﹤0.01% | 1392 |
|
|
2023
Q4 | $662K | Buy |
10,060
+60
| +0.6% | +$3.95K | ﹤0.01% | 1270 |
|
|
2023
Q3 | $570K | Hold |
10,000
| – | – | ﹤0.01% | 1254 |
|
|
2023
Q2 | $613K | Hold |
10,000
| – | – | ﹤0.01% | 1262 |
|
|
2023
Q1 | $627K | Hold |
10,000
| – | – | ﹤0.01% | 1246 |
|
|
2022
Q4 | $634K | Hold |
10,000
| – | – | ﹤0.01% | 1185 |
|
|
2022
Q3 | $589K | Hold |
10,000
| – | – | ﹤0.01% | 1208 |
|
|
2022
Q2 | $577K | Hold |
10,000
| – | – | ﹤0.01% | 1203 |
|
|
2022
Q1 | $620K | Hold |
10,000
| – | – | ﹤0.01% | 1235 |
|
|
2021
Q4 | $712K | Hold |
10,000
| – | – | ﹤0.01% | 1182 |
|
|
2021
Q3 | $748K | Hold |
10,000
| – | – | ﹤0.01% | 1103 |
|
|
2021
Q2 | $773K | Hold |
10,000
| – | – | ﹤0.01% | 1025 |
|
|
2021
Q1 | $738K | Hold |
10,000
| – | – | 0.01% | 888 |
|
|
2020
Q4 | $701K | Buy |
+10,000
| New | +$701K | 0.01% | 803 |
|